Related references
Note: Only part of the references are listed.Synergistic Effect between Colistin and Bacteriocins in Controlling Gram-Negative Pathogens and Their Potential To Reduce Antibiotic Toxicity in Mammalian Epithelial Cells
Karim Naghmouchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
Celine Vidaillac et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Colistin: new lessons on an old antibiotic
D. Yahav et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Lacticin 3147-Biosynthesis, Molecular Analysis, Immunity, Bioengineering and Applications
Srinivas Suda et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2012)
Efficacy of Organic Acids, Bacteriocins, and the Lactoperoxidase System in Inhibiting the Growth of Cronobacter spp. in Rehydrated Infant Formula
Satoru Oshima et al.
JOURNAL OF FOOD PROTECTION (2012)
The Other Gram-Negative Bacteria in Mastitis Klebsiella, Serratia, and More
Ynte Schukken et al.
VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE (2012)
Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli
Karim Naghmouchi et al.
RESEARCH IN MICROBIOLOGY (2011)
The ABC Transporter AnrAB Contributes to the Innate Resistance of Listeria monocytogenes to Nisin, Bacitracin, and Various β-Lactam Antibiotics
Barry Collins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria
James Carroll et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis
Katja Klostermann et al.
JOURNAL OF DAIRY RESEARCH (2010)
Structure-Activity Relationships of Polymyxin Antibiotics
Tony Velkov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Lantibiotics: Mode of Action, Biosynthesis and Bioengineering
G. Bierbaum et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2009)
A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species
Clare Piper et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Synergistic effects of Miconazole and Polymyxin B on microbial pathogens
Silvia Pietschmann et al.
VETERINARY RESEARCH COMMUNICATIONS (2009)
Mammary pathogenic Escherichia coli
Nahum Y. Shpigel et al.
CURRENT OPINION IN MICROBIOLOGY (2008)
Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms
Zhe Yuan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains
Mary C. Rea et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
The mode of action of the lantibiotic lacticin 3147 -: a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II
Imke Wiedemann et al.
MOLECULAR MICROBIOLOGY (2006)
Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147
Paul D. Cotter et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis
SK Kasiakou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations
SM Morgan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Biosynthesis and mode of action of lantibiotics
C Chatterjee et al.
CHEMICAL REVIEWS (2005)
Polymyxins: Pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications
ED Hermsen et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii
EJ Giamarellos-Bourboulis et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2001)
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines
AC Gales et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
